US Broker Ratings

Talkspace, Inc. (TALK) Stock Analysis: Unveiling a 35.98% Potential Upside

Investors seeking opportunities in the healthcare sector should closely examine Talkspace, Inc. (NASDAQ: TALK), a virtual behavioral healthcare provider with an intriguing growth story and notable..

Definitive Healthcare Corp. (DH) Investor Outlook: Exploring a 126.95% Potential Upside

Definitive Healthcare Corp. (NASDAQ: DH) stands as a notable entity within the healthcare sector, specifically in the health information services industry. Founded in 2011 and headquartered..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 147% Upside in the Biotech Sector

Sana Biotechnology, Inc. (NASDAQ: SANA), a burgeoning player in the healthcare sector, is making waves in the biotechnology industry with its ambitious approach to cell-based therapies...

Butterfly Network, Inc. (BFLY) Stock Analysis: Impressive Revenue Growth and a 48% Upside Potential

Butterfly Network, Inc. (NASDAQ: BFLY) is making waves in the healthcare sector with its innovative approach to ultrasound imaging solutions. As a player in the medical..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: A 44% Potential Upside with a Strong Buy Consensus

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) is capturing attention in the healthcare sector with its focus on specialty pharmaceuticals, particularly in the domain of pain management. With..

KalVista Pharmaceuticals (KALV) Stock Analysis: Harnessing Biotech Innovation with a 109.75% Upside Potential

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is making waves in the biotechnology sector with its pioneering approach to treating hereditary angioedema (HAE), a rare and potentially life-threatening..

Cogent Biosciences, Inc. (COGT)

⚠️ No article content returned.

..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Biotech Innovator with 144.99% Potential Upside

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is capturing investor attention with its promising pipeline of gene therapies targeting monogenic diseases of the central nervous system. The..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Strong Buy Ratings Signal Significant Growth Potential

Relay Therapeutics, Inc. (NASDAQ: RLAY) is capturing the attention of investors with its compelling growth potential within the biotechnology sector. With a market capitalization of $1.72..

Geron Corporation (GERN) Stock Analysis: Exploring a 139% Potential Upside in Biotech

Geron Corporation (NASDAQ: GERN), a commercial-stage biopharmaceutical firm based in Foster City, California, has captured the attention of investors with its ambitious product pipeline and significant..

Pharvaris N.V. (PHVS) Stock Analysis: Exploring a 76.62% Potential Upside in the Biotech Sector

Pharvaris N.V. (PHVS) is capturing the attention of investors with its promising potential upside in the competitive biotechnology sector. With a market capitalization of $1.68 billion,..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Exploring a 61.32% Potential Upside in the Biotech Sector

Zenas BioPharma, Inc. (ZBIO), a promising player in the biotechnology industry, has been catching the eye of investors with its innovative approach to immunology-based therapies. Headquartered..

Bicara Therapeutics Inc. (BCAX) Stock Report: Analyzing a 58% Potential Upside in the Biotech Arena

Bicara Therapeutics Inc. (NASDAQ: BCAX) has been attracting significant attention from investors, particularly those with a keen eye on the biotechnology sector. With a market capitalization..

Stoke Therapeutics, Inc. (STOK) Stock Report: Exploring a 20% Upside Potential and Strong Buy Ratings

Stoke Therapeutics, Inc. (NASDAQ: STOK) has emerged as a formidable contender in the biotechnology sector, captivating investor interest with its promising pipeline of treatments for severe..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Unpacking the 79.87% Potential Upside for Investors

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a dynamic player in the healthcare sector, has piqued the interest of investors with its impressive potential upside of 79.87%. Specializing..

Xencor, Inc. (XNCR) Stock Analysis: A Biotech Player with 158% Potential Upside

In the ever-dynamic world of biotechnology, Xencor, Inc. (NASDAQ: XNCR) stands out as a promising player with a diverse pipeline of innovative therapies targeting cancer and..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a Potential 76.82% Upside in Genetic Therapy Innovations

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a key player in the biotechnology sector, stands out with its focus on developing genetic therapies for rare and life-threatening diseases...

Enhabit, Inc. (EHAB) Stock Analysis: Navigating the Healthcare Sector with a Strong 52-Week Surge

Enhabit, Inc. (NASDAQ: EHAB), a notable player in the healthcare sector specializing in home health and hospice services, has captured investor attention with its remarkable stock..

STAAR Surgical Company (STAA) Stock Analysis: Is a 12% Upside Within Reach for This Healthcare Innovator?

STAAR Surgical Company (NASDAQ: STAA) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of..

Zymeworks Inc. (ZYME) Stock Analysis: Potential 51% Upside Amidst Strong Buy Ratings

Zymeworks Inc. (NASDAQ: ZYME) stands out in the biotechnology sector with its innovative approach to developing biotherapeutics for cancer and autoimmune diseases. With a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds